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This study examines the cellular immune factors respon ible for combating infections by assessing CD4 and CD8 
counts of neonates (pre and post BCG vaccination). A total of 373 blood samples were collected from neonates that 
visited the immunization clinics at Irrua Specialist Teaching Hospital (ISTH), Irrua and Federal Medical Centre 
(FMC), Asaba, Nigeria. CD4 and CD8 easy count kit (Partec, Germany) was used for the determination of CD4 and 
CD8 count respectively, while the samples were analysed using SL-blue Cyflow.  At ISTH Irrua, 191 samples were 
analyzed (130:60; pre and post vaccination), while at Asaba, 182 samples were analysed (120:62; pre and post 
vaccination). The results showed that CD4 count was significantly higher for Pre vaccination than Post vaccination 
at both locations. At FMC Asaba, the CD4 count for females was significantly higher than in males (pre-BCG 
vaccination), while CD4 count was not significantly affected by gender at Irrua, ISTH. CD8 increases in both 
locations but was not significantly affected by gend r. The findings of this study therefore suggests that there is a 
cell mediated immune response to BCG vaccine by both the male and female neonates and this is associated wi h a 
decrease in CD4 count (post vaccination). 
 




Tuberculosis is a major public health disease and has been described as humanity’s greatest killer (WHO, 2002; 
Cadmus et al., 2011). The disease is increasing at an alarming rate primarily due to the absence of an effective 
vaccine, the emergence of multi-drug resistant strains, as well as co-infection with HIV and low diagnostic and 
therapeutic coverage (Acosta et al., 2010). 
 
Bacillus Calmette Guerin (BCG) is the only available vaccine against tuberculosis and has been in use for over 
seventy years (Pinto et al, 2004; Kassyam et al, 2010). BCG consist of an attenuated strain of Mycobacterium bovis, 
which has been reported with varied efficacy (0–80%) depending on the studies and geographical locations 
(Glassroth, 1997, Brodin et al, 2004; Pinto et al, 2004). In spite of this, more people have been vaccin ted with BCG 
than any other vaccine (Ota et al, 2002). Although the efficacy of BCG vaccine against the disease in adult is 
variable, it protects against childhood disease (Ota et al, 2002). Presently in Nigeria, BCG is administered to 
children at birth (one dose of 0.05ml) and it is usually not administered to children who have clinical HIV/AIDS 
(NPI, 2004). 
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Mycobacterial infections induce humoral and cell mediated immune responses, in which the contribution of 
macrophages, CD4 and CD8 T-lymphocytes is essential (Levison and Jawetz, 1998; Gil et al, 2004). Both animal 
and human data support the key role of CD4 T-cells in the control of Mycobacterium tuberculosis (Chackerian et al., 
2001). Greater morbidity and mortality in CD4 depleted mice confirm the critical role of this T-cell subset 
(Chackerian et al, 2001). The resurgence of tuberculosis associated with HIV epidemic also demonstrates that loss 
of CD4 T-cells increases susceptibility to tuberculosis (Sonneberg et al, 2001). 
 
The aim of this study therefore, is to determine the CD4 and CD8 counts of neonate’s (pre and post vaccin tion-six 
weeks after BCG was administered) with the objectiv of determining the gender differences. 
 
MATERIALS AND METHODS 
 
Study Area: The study was conducted at the Irrua Specialist Teaching Hospital (ISTH) Irrua and Federal Medical 
Centre (FMC) Asaba, both in Nigeria. Irrua is the administrative headquarters of Esan Central Local Government 
Area, Edo State and ISTH is a designated centre for the National Programme for Immunization (NPI, 2004), where 
routine immunization is rendered to children 0 to 59 months. 
 
Asaba on the other hand, is the state Capital of Delta State and is located on the right bank of the riv r Niger. The 
Federal Medical Centre in Asaba renders routine immunization to children 0 – 59 months within the city and other 
neighbouring towns. 
 
Inclusion criteria: The study targets children 0 to 28 days old (neonates) who were born in these hospitals and 
registered in the immunization clinic at the time of this study. 
 
Exclusion criteria: Children that were 30 days old and above, pre-termed babies and those born with aliments were 
excluded in this study. 
 
Ethical consideration: Ethical approval was sought and granted by the resarch and ethic committee of ISTH, Irrua 
and FMC Asaba, while informed consent was obtained from the parents of the neonates. 
 
Duration of Study: The study was conducted within a six months period (June to December, 2011). 
 
Study Design: The study adopted the cohort study design. 
 
Method of sample collection: A total of three hundred and seventy (373) blood samples were collected from 
neonates attending immunization clinics at Irrua Specialist Teaching Hospital, Irrua and Federal Medical Centre, 
Asaba. The samples were collected by pediatricians using 21G and 23G needles into EDTA vacutainers. 1ml of 
venous blood was collected from each neonate before BCG vaccine was administered (Pre-BCG vaccination) and 
six (6) weeks after BCG was administered (Post-BCG vaccination). The samples were transported to the laboratory 
in geostyles (vaccine carriers) containing frozen ice – packs. 
 
Method of Sample analysis: The CD4 % easy count partec kit (05 – 8405) and CD8 easy count partec kit (05 – 
8801) were used for the determination of CD4 and CD8 counts respectively. 
 
In analyzing for CD4, 20µl of whole blood was dispens d into a corresponding partec test tube and 10µl of CD4 
monoclonal ABPE and 10µl of CD45 monoclonal ABPE – DY647 was added. The contents were properly mixed 
and incubated at room temperature in the dark for 15 minutes. After which, 400µl of buffer 1 was added and mixed. 
400µl of buffer 2 was added mixed and each sample was analyzed immediately using SL – blue Partec cyflow 
(Balakrishnan et al., 2005). 
 
CD8 count was determined by dispensing 20µl of whole blood into Partec tube and adding 20µl of CD8 m ABPE. 
The contents was gently mixed and incubated at room temperature in the dark for 15 minutes, 800µl of buf er was 
added, properly mixed and each sample was analyzed using SL – blue Partec cyflow (Ray et al., 2006). 
 
Data analysis: Statistical analysis was done using the student “t” test to determine level of significance. A p- value 








The effect of BCG vaccination on CD4 and CD8 count in Irrua and Asaba is shown in Figures 1 and 2 respectively. 
CD4 count was significantly higher pre BCG vaccination than CD4 count post vaccination in both locations. CD8 
count increased at both locations post BCG vaccinatio . Figure 3 shows the effect of BCG vaccination on CD4 
count of male and female neonates at Irrua and Asaba, while Fig 4 shows the effect of BCG vaccination on CD8 
count of male and female neonates in Asaba and Irrua. In Asaba, CD4 count for females was significantly higher 
than in males pre BCG vaccination (P < 0.05). On the other hand, CD4 count was not significantly affected by 
gender at Irrua.  CD8 count was not significantly affected by gender at both locations. 
 
 
Figure 1: Effect of BCG vaccination on CD4 count in Irrua and Asaba 
 
 




Figure 3: CD4 count of male and female infants in  Asaba and Irrua 
 
Anthonio Research Center © 2012 173       Eyaufe et al.., IJBAIR; 1(4): 170-175 
 
 
Figure 4: CD8 count of male and female infants in  Asaba and Irrua 
DISCUSSION 
 
CD4 count (pre BCG-vaccination) was significantly higher than CD4 count (post vaccination) at both locations 
(p<0.05). This decrease is at variance with studies one by Hanekom (2005), where there was quantitative increase 
in the proliferation of CD4 cells. However Kagina et al. (2009) reports that CD4 T cell response is heightened when 
BCG is given at 10 weeks instead of at birth. In this study, BCG was administered at birth. 
 
Also, the observed increase in CD8 count at both locati ns agrees with the studies by Hanekom (2005), where CD8 
T cells with cytotoxic potential were produced after BCG vaccination, though CD8 T cell proliferation was 
quantitatively lower than that of CD4 Tcells. 
 
Available literature show that mycobacterium induces CD8 T cell responses in humans (Flynn et al., 2004) and large 
body of evidence supports a role for CD8 T cells in protection against tuberculosis (Grotzke and Lewinsohn, 2005). 
However, CD4 T cells are more important in acute infection whereas CD8 T cells are responsible for the 
containment of latent infection (Van Pinxteren et al., 2000). 
 
In Asaba, CD4 count of females was significantly higher than in males (pre-BCG vaccination), but was not 
significantly affected by gender at Irrua. Males had significantly higher levels of CD8 counts than females (pre and 
post BCG vaccination) at Irrua, while at Asaba, CD8 count was not significantly affected by gender. Although Benn 
and Aaby (2007) asserts that gender can affect immune response to BCG vaccine, Wilson et al (1995) reported 
however, that many factors may influence host respon e to BCG vaccine. These factors include socio-economic 
conditions, genetic composition of the population, climate, exposure to sunlight, diet and nutrition. 
 
The findings of this study therefore, have shown that gender is just one of the many factors that can affect response 
to BCG vaccine by neonates. Furthermore, it has also revealed that there is cell mediated immune respon e to the 
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